Headache

Future migraine biomarkers research: lipids 0:56
Future migraine biomarkers research: lipids
Gisela Terwindt • 1 Sep 2021
Key updates on pediatric and adolescent headache practice guidelines 3:41
Key updates on pediatric and adolescent headache practice guidelines
Andrew Hershey • 2 Sep 2021
Eptinezumab initiated during a migraine prolongs time to subsequent attacks 4:37
Eptinezumab initiated during a migraine prolongs time to subsequent attacks
Roger Cady • 15 Jun 2021
Factors associated with decreased migraine attack risk 3:35
Factors associated with decreased migraine attack risk
Christian Wöber • 14 Jun 2021
Patient-identified most bothersome symptom as a novel outcome measure in migraine prevention trials 2:41
Patient-identified most bothersome symptom as a novel outcome measure in migraine prevention trials
Roger Cady • 15 Jun 2021
N1-Headache: a tool for personalized migraine management 2:00
N1-Headache: a tool for personalized migraine management
Christian Wöber • 14 Jun 2021
How does eptinezumab differ from other migraine treatments? 2:27
How does eptinezumab differ from other migraine treatments?
Roger Cady • 15 Jun 2021
RELIEF trial results: eptinezumab demonstrates efficacy when administered during a migraine attack 4:47
RELIEF trial results: eptinezumab demonstrates efficacy when administered during a migraine attack
Roger Cady • 15 Jun 2021
Visuospatial processing in patients with migraine 3:21
Visuospatial processing in patients with migraine
Roberta Messina • 17 Jun 2021
Imaging biomarkers in migraine 2:52
Imaging biomarkers in migraine
Roberta Messina • 17 Jun 2021
Beyond CGRP: psychedelics for the treatment of migraine 4:16
Beyond CGRP: psychedelics for the treatment of migraine
Jessica Ailani • 21 Jun 2021
Lessons learned from neuroimaging in migraine 2:21
Lessons learned from neuroimaging in migraine
Roberta Messina • 17 Jun 2021
Migraine symptom resolution occurs within an hour with eptinezumab administered during an attack 6:17
Migraine symptom resolution occurs within an hour with eptinezumab administered during an attack
Jessica Ailani • 21 Jun 2021
Total pain burden reduced by galcanezumab in treatment-resistant migraine 6:19
Total pain burden reduced by galcanezumab in treatment-resistant migraine
Jessica Ailani • 21 Jun 2021
Resting state functional connectivity changes of the pons in migraine 2:52
Resting state functional connectivity changes of the pons in migraine
Roberta Messina • 17 Jun 2021
Can patients predict an upcoming cluster headache bout? 1:45
Can patients predict an upcoming cluster headache bout?
Rigmor Jensen • 11 Jun 2021
The content of VJNeurology is intended for healthcare professionals